- Home
- VANI vs INCR Comparison
VANI vs INCR Comparison
Compare VANI & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- INCR
- Stock Information
- Founded
- VANI 1998
- INCR 1994
- Country
- VANI United States
- INCR Israel
- Employees
- VANI N/A
- INCR N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- VANI Health Care
- INCR Health Care
- Exchange
- VANI Nasdaq
- INCR Nasdaq
- Market Cap
- VANI 69.3M
- INCR 76.7M
- IPO Year
- VANI 2014
- INCR N/A
- Fundamental
- Price
- VANI $1.15
- INCR $1.64
- Analyst Decision
- VANI Strong Buy
- INCR
- Analyst Count
- VANI 1
- INCR 0
- Target Price
- VANI $3.00
- INCR N/A
- AVG Volume (30 Days)
- VANI 83.2K
- INCR 29.7K
- Earning Date
- VANI 03-25-2025
- INCR 03-04-2025
- Dividend Yield
- VANI N/A
- INCR N/A
- EPS Growth
- VANI N/A
- INCR N/A
- EPS
- VANI N/A
- INCR N/A
- Revenue
- VANI N/A
- INCR $72,420,918.00
- Revenue This Year
- VANI N/A
- INCR N/A
- Revenue Next Year
- VANI N/A
- INCR $39.30
- P/E Ratio
- VANI N/A
- INCR N/A
- Revenue Growth
- VANI N/A
- INCR N/A
- 52 Week Low
- VANI $1.01
- INCR $1.17
- 52 Week High
- VANI $7.80
- INCR $3.72
- Technical
- Relative Strength Index (RSI)
- VANI 43.02
- INCR 48.90
- Support Level
- VANI $1.12
- INCR $1.61
- Resistance Level
- VANI $1.19
- INCR $1.73
- Average True Range (ATR)
- VANI 0.03
- INCR 0.06
- MACD
- VANI 0.00
- INCR -0.01
- Stochastic Oscillator
- VANI 42.86
- INCR 35.48
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.